Related Experiment Videos
The multi-face expression of familial Mediterranean fever in the child
D Rigante1, I La Torraca, V Ansuini
1Centre of Periodic Fevers, Department of Pediatric Sciences, Università Cattolica del Sacro Cuore, Rome, Italy. drigante@rm.unicatt.it
Abstract:
Familial Mediterranean fever (FMF) is characterized by recurrent self-limiting flares of fever in the absence of pathogens, autoantibodies or antigen specific T cells and is inherited as an autosomal recessive trait probably deriving from common ancestors of Armenian, Jew, Turk and Arab origin. The underlying pathogenetic mechanisms of FMF have not been fully interpreted, but mutations in the gene MEFV encoding pyrin, a natural repressor of proinflammatory molecules, result in uncontrolled relapsing systemic inflammation, increased leukocyte migration to serosal membranes or joints and inappropriate response to inflammatory stimuli. FMF heterogeneous phenotypic expression could originate both from allelic heterogeneity or from the existence of modulating genes. Proper diagnosis of FMF is needed to begin both specific clinical management and treatment based on continuous prophylactic administration of colchicine, preventing flares or at least the onset of amyloidosis.
Insights
Familial Mediterranean fever (FMF) is an inherited autoinflammatory disorder caused by MEFV gene mutations. Early diagnosis and colchicine treatment are crucial for managing FMF flares and preventing amyloidosis.
Area of Science:
- Genetics
- Immunology
- Rheumatology
Background:
- Familial Mediterranean fever (FMF) is an autoinflammatory disorder characterized by recurrent fevers.
- It is inherited as an autosomal recessive trait, common in specific ancestral groups.
- The exact pathogenetic mechanisms are not fully understood.
Purpose of the Study:
- To summarize the understanding of FMF pathogenesis, genetic basis, and clinical management.
- To highlight the importance of early diagnosis and treatment.
Main Methods:
- Review of existing literature on FMF genetics, clinical presentation, and treatment.
- Analysis of the role of MEFV gene mutations and pyrin protein in FMF.
Main Results:
- Mutations in the MEFV gene, encoding pyrin, lead to uncontrolled systemic inflammation.
- Pyrin acts as a natural repressor of proinflammatory molecules.
- FMF presents with heterogeneous phenotypes, potentially due to allelic heterogeneity or modulating genes.
Conclusions:
- Accurate diagnosis of FMF is essential for timely clinical management.
- Continuous prophylactic administration of colchicine is the standard treatment.
- Colchicine helps prevent FMF flares and the development of amyloidosis.
Related Concept Videos
Rocky Mountain Spotted Fever
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Myocarditis II: Clinical Features and Diagnostic Tests
Asthma III: Clinical Manifestations
Inflammatory Bowel Disease IV: Clinical Manifestations
Myocarditis I: Introduction